Tung-Cheng Chang

View Scopus Profile

Emailrousse11tmu.edutw

h-index

Research activity per year

Education

1996-2003 M.D., School of Medicine, National Cheng Kung University

Experience

2022.02- Associate Professor, Department of Surgery, School of Medicine, Taipei Medical University
Director, Division of Colorectal Surgery, Department of Surgery, Taipei Medical University Shuang Ho Hospital
Attending Surgeon, Division of Colorectal Surgery, Department of Surgery, Taipei Medical University Shuang Ho Hospital
2018.08-2022.01 Assistant Professor, Department of Surgery, School of Medicine, Taipei Medical University
2010.02-2018.07 Instructor, Department of Surgery, School of Medicine, Taipei Medical University
2008.08-2009.07 Attending Physician, Division of General Surgery, National Taiwan University Hospital Yunlin Branch
2008.05-2008.07 Researcher, Division of Gastroenterological Surgery, National Cancer CenterJapan，NCC
2006.07-2008.07 Chief Resident Physician, Division of General Surgery, National Taiwan University Hospital
2003.07-2008.07 Resident Physician, Division of Surgery, National Taiwan University Hospital

Research Interests

一般外科

Fingerprint

Dive into the research topics where Tung-Cheng Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

1 Active
3 Finished

Exploring Sh3rf3 as a Biomarker and Target for Overcoming Cetuximab Resistance and Preventing Kras Mutations in Colorectal Cancer
Chang, T.-C. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
HMGA2, a New Target of Thyroid Hormone-Induced Progression in Colorectal Cancers
Lin, H.-Y. (PI), Chang, T.-C. (CoI) & Yen, Y. (CoI)
8/1/15 → 7/31/16
Project: A - Government Institution › b - National Science and Technology Council
Tetrac於初代大腸癌細胞中強化白藜蘆醇誘導之
Chang, T.-C. (PI)
6/1/14 → 5/31/15
Project: C - Project of Alliance › u - Taipei Medical University Shuang Ho Hospital
探討antimycin A 在抗輻射性肝癌幹細胞之功效
Chang, T.-C. (PI)
5/1/13 → 4/30/14
Project: C - Project of Alliance › u - Taipei Medical University Shuang Ho Hospital

54 Article
2 Letter
1 Comment/debate

Integrin αvβ3-dependent pathogenic effect and therapeutic effects of DL-N2 combined with EGFR inhibitors in pancreatic adenocarcinoma
Li, Z. L., Kumar, S., Yang, S. N., Chang, T. C., Huang, L. Y., Ko, C. C., Yang, Y. N., Yao, C. J., Crawford, D. R., Gionfra, F., Solomon, D. D., Lee, Y. K., Xuan, D. T. M., Lin, H. R., Wang, C. Y., Aher, A., Abhista, N. B., Shih, Y. J., Lee, S. Y. & Huang, H. M. & 3 others, Lin, H. Y., Wang, K. & Whang-Peng, J., Dec 2026, In: Journal of Translational Medicine. 24, 1, 321.
Research output: Contribution to journal › Article › peer-review

Open Access
SIAH2–WNK1 Signaling Drives Glycolytic Metabolism and Therapeutic Resistance in Colorectal Cancer
Kiu, K. T., Chu, C. Y., Cheng, Y. C., Yen, M. H., Chen, Y. W., Pikatan, N. W., Yadav, V. K. & Chang, T. C., Jan 2026, In: International journal of molecular sciences. 27, 2, 1065.
Research output: Contribution to journal › Article › peer-review

Open Access
Clinical impact of pharmacogenetic risk variants in a large chinese cohort
Wei, C. Y., Wen, M. S., Cheng, C. K., Sheen, Y. J., Yao, T. C., Lee, S. L., Wu, J. Y., Tsai, M. F., Li, L. H., Chen, C. H., Fann, C. S. J., Yang, H. C., Huang, Y. T., Chen, H. H., Liu, Y. M., Yeh, E. C., Peng, Y. C., Wang, S. J., Chen, S. P. & Tsai, M. T. & 104 others, Huo, T. I., Su, C. W., Tarng, D. C., Huang, C. C., Fuh, J. L., Lan, K. H., Liu, Y. T., Lu, C. L., Lee, Y. C., Huang, Y. H., Li, C. P., Wang, Y. F., Hsieh, Y. C., Chen, Y. M., Hsiao, T. H., Lin, C. H., Chen, Y. J., Chen, I. C., Mao, C. L., Chang, S. J., Chang, Y. L., Liao, Y. J., Lai, C. H., Lee, W. J., Tung, H., Yen, T. T., Yen, H. C., Chang, J. H., Huang, C. Y., Chan, L., Lin, Y. W., Hsiao, B. Y., Hu, C. J., Lin, Y. K., Lin, Y. F., Chang, T. C., Wu, D. C., Kan, J. Y., Hsu, C. Y., Chen, S. C., Li, C. C., Huang, C. F., Sheu, C. C., Yang, L. J., Chen, C. H., Chen, K. M., Chang, S. M., Liou, M. S., Wang, S. P., Lin, K. T., Chuang, H. P., Chen, Y. J., Sin, J., Chen, Y. T., Chang, C. C., Kuo, C. F., Lin, J. C., Kuo, H. C., Chan, T. M., Lee, C. W., Lai, J. H., Luo, S. F., Cheng, H. T., Lin, L. Y., Chang, L. C., Tsai, C. T., Kao, H. L., Yu, J. J., Jeng, J. S., Chiu, M. C., Hong, T. C., Yang, S. F., Lu, H. J., Su, S. C., Chu, P., Li, P. F., Tsai, C. L., Tsai, C. K., Tang, S. E., Lin, C. M., Wu, Y. F., Huang, C. Y., Ling, S. Z., Chang, C. C., Lin, T. K., Hsiao, S. M., Chang, C. H., Chen, C. D., Ma, G. C., Chang, T. Y., Hwang, J. J., Lu, C. L., Kao, K. J., Hung, C. F., Chen, S. S., Chen, P. Y., Tsui, K., Chen, Y. T., Chen, C. H., Chien, C. C., Chiang, H. S., Chiu, Y. L., Chen, H. C. & Kwok, P. Y., Dec 2025, In: Nature Communications. 16, 1, 6344.
Research output: Contribution to journal › Article › peer-review
6 Link opens in a new tab Citations (Scopus)
Exploring diarylheptanoid derivatives to target LIMK1 as potential agents against colorectal cancer
Chen, L. C., Chang, T. C., Tseng, H. J., Chu, J. C., Huang, Y. Y., Peng, H. Y., Kuo, Y. C., Wu, Y. W., Lin, T. E., Yen, S. C., Hsu, K. C., Huang, W. J. & Pan, S. L., Dec 2025, In: Journal of Enzyme Inhibition and Medicinal Chemistry. 40, 1, p. 2583826 2583826.
Research output: Contribution to journal › Article › peer-review

Open Access
Preoperative enema for anal surgery: Randomized clinical trial
Tsai, M. C., Su, T. Y., Kiu, K. T., Yen, M. H., Chen, Y. W., Tam, K. W., Huu, T. L. & Chang, T. C., Jun 2025, In: BJS open. 9, 3, zraf023.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Link opens in a new tab Citation (Scopus)

Tung-Cheng Chang

Personal profile

Education

Experience

Research Interests

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Exploring Sh3rf3 as a Biomarker and Target for Overcoming Cetuximab Resistance and Preventing Kras Mutations in Colorectal Cancer

HMGA2, a New Target of Thyroid Hormone-Induced Progression in Colorectal Cancers

Tetrac於初代大腸癌細胞中強化白藜蘆醇誘導之

探討antimycin A 在抗輻射性肝癌幹細胞之功效

Integrin αvβ3-dependent pathogenic effect and therapeutic effects of DL-N2 combined with EGFR inhibitors in pancreatic adenocarcinoma

SIAH2–WNK1 Signaling Drives Glycolytic Metabolism and Therapeutic Resistance in Colorectal Cancer

Clinical impact of pharmacogenetic risk variants in a large chinese cohort

Exploring diarylheptanoid derivatives to target LIMK1 as potential agents against colorectal cancer

Preoperative enema for anal surgery: Randomized clinical trial

Tung-Cheng Chang

Personal profile

Education

Experience

Research Interests

Fingerprint

Collaborations and top research areas from the last five years

Projects

Research output